Table 2 Abortion indications in three groups under study
Abortion indications | Groups | P-value* | |||
|---|---|---|---|---|---|
Misoprostol n = 30 | Misoprostol + Methylergometrine n = 30 | Misoprostol + Oxytocin n = 30 | |||
Bleeding | Mild | 16 (53.33( | 24 (80) | 19(63.33) | 0.627 |
Moderate | 5 (16.67%) | 1 (3.33) | 4(13.33) | ||
Severe | 1 (3.33) | 0 (0) | 1(3.33 ) | ||
No bleeding | 8(26.67) | 5(16.67) | 6(20) | ||
Pain | None to Mild(VAS = 0–3) | 13 (43.33) | 20(66.66) | 17 (56.66) | 0.004 |
Moderate (VAS = 4–6) | 11(36.66) | 10(33.33 ) | 8(26.66 ) | ||
Severe (VAS = 7–10) | 6(20) | 0( 0) | 5(16.66) | ||
Spotting | Yes | 3 (10) | 3 (10) | 4 (13.3) | 0.894 |
No | 27(90) | 27(90) | 26(86.7) | ||